Show simple item record

dc.contributor.authorLønning, P
dc.contributor.authorBerge, E
dc.contributor.authorBjørnslett, M
dc.contributor.authorMinsaas, L
dc.contributor.authorChrisanthar, R
dc.contributor.authorHøberg-Vetti, H
dc.contributor.authorDulary, C
dc.contributor.authorBusato, F
dc.contributor.authorBjørneklett, S
dc.contributor.authorEriksen, C
dc.contributor.authorKopperud, R
dc.contributor.authorAxcrona, U
dc.contributor.authorDavidson, B
dc.contributor.authorBjørge, L
dc.contributor.authorEvans, G
dc.contributor.authorHowell, Anthony
dc.contributor.authorSalvesen, H
dc.contributor.authorJanszky, I
dc.contributor.authorHveem, K
dc.contributor.authorRomundstad, P
dc.contributor.authorVatten, L
dc.contributor.authorTost, J
dc.contributor.authorDørum, A
dc.contributor.authorKnappskog, S
dc.date.accessioned2018-04-29T21:02:52Z
dc.date.available2018-04-29T21:02:52Z
dc.date.issued2018-03-06
dc.identifier.citationWhite blood cell BRCA1 promoter methylation status and ovarian cancer risk. 2018, 168(5): 326-334 Ann Intern Meden
dc.identifier.issn1539-3704
dc.identifier.pmid29335712
dc.identifier.doi10.7326/M17-0101
dc.identifier.urihttp://hdl.handle.net/10541/620926
dc.description.abstractThe role of normal tissue gene promoter methylation in cancer risk is poorly understood.
dc.language.isoenen
dc.rightsArchived with thanks to Annals of internal medicineen
dc.titleWhite blood cell BRCA1 promoter methylation status and ovarian cancer risk.en
dc.typeArticleen
dc.contributor.departmentUniversity of Bergen and Haukeland University Hospital, Bergen, Norwayen
dc.identifier.journalAnnals of Internal Medicineen
html.description.abstractThe role of normal tissue gene promoter methylation in cancer risk is poorly understood.


This item appears in the following Collection(s)

Show simple item record